bioAffinity Technologies, Inc. 8-K

What Happened

• bioAffinity Technologies, Inc. (BIAF) filed a Form 8-K on March 26, 2026 (Regulation FD disclosure) saying it prepared presentation materials that management will use in presentations about the company’s operations and performance.
• The Presentation Materials were posted to the company’s website the same day and are furnished as Exhibit 99.1 to the 8-K.

Key Details

• Filing date: March 26, 2026.
• Document: Form 8-K, Item 7.01 (Regulation FD Disclosure).
• Exhibit included: 99.1 – Presentation Materials (also referenced Exhibit 104 – Cover Page Interactive Data File).
• Management intends to use the materials in future presentations; materials were made publicly available on the company website.

Why It Matters

• This 8-K is a public disclosure under Regulation FD, meaning the company made these presentation materials broadly available rather than communicating them privately.
• Investors should review the posted presentation (Exhibit 99.1) for any updates on strategy, operations or performance metrics; the filing itself does not report earnings, executive changes, mergers, or other material events.
• Because the filing is informational, monitor the company’s website and future SEC filings for any material announcements that would affect financial results or valuation.